Adam Buvis
On behalf of Jerry Ravitch, Goldman Sachs
Replay available
CAMP4 Therapeutics Corporation (NASDAQ: CAMP) Q4 2023 earnings conference call, held 2023-04-27. Replay captured from the company's public earnings webcast.

On behalf of Jerry Ravitch, Goldman Sachs
President & CEO, CalAMP
Managing Director, Shelton Group (Investor Relations)
Chief Financial Officer, CalAMP
Jefferies
Northland Capital Markets
Oppenheimer
Welcome to CalAMP's fourth quarter and fiscal year 2023 financial results conference call. My name is Tia and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star one on your telephone keypad. As a reminder, this call is being recorded. I would now like to introduce your host for today's conference call, Joel Arkamowitz. Managing Director of Shelton Group, CalAMP's Investor Relations Firm. Joel, you may begin. Good afternoon and welcome to CalAMP's fourth quarter in the fiscal year 2023 Financial Results Conference Call. I'm Joel Akramowitz, Managing Director of Shelton Group, CalAMP's Investor Relations Firm. With us today are CalAMP's President and Chief Executive Officer, Jeff Gardner, and Chief Financial Officer, Jikon Kim. Before we begin, I'd like to remind you that this call may contain forward-looking statements. While these forward-looking statements reflect CalM's best current judgment, they're subject to risks and uncertainties that could cause actual results to differ materially from those implied by these forward-looking projections. These risk factors are discussed in our regular SEC filings and in the hearings released issued today, which are available on our website. We undertake no obligation to revise or update any forward-looking statements to reflect future events or circumstances. Now, Jeff will begin today's call with a review of the company's recent operational highlights, and then G-Con will provide a more detailed review of the financial results, followed by a question and answer session. With that, it's my great pleasure to turn the call over to CalAMS President and CEO, Je...